Conformational Constraint between Aromatic Residue Side Chains in the “Message” Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist | Journal of
The neurobiology of addiction - Uhl - 2019 - Annals of the New York Academy of Sciences - Wiley Online Library
κ-opioid receptor - Wikipedia
A single, extinction-based treatment with a kappa opioid receptor agonist elicits a long-term reduction in cocaine relapse | Neuropsychopharmacology
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Stress‐related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective - Heilig - 2023 - Journal of Internal Medicine - Wiley Online Library
A Role for Brain Stress Systems in Addiction: Neuron
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat | Request PDF
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
The Neuroscience of Drug Reward and Addiction | Physiological Reviews
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction | SpringerLink
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. - YouTube
PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age | Neuropsychopharmacology
Pharmacy | Free Full-Text | The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
Selective kappa opioid antagonists for treatment of addiction, are we there yet? - ScienceDirect